Vps34-IN-2 - ≥99% , CAS No.1523404-29-6

CAS: 1523404-29-6 Cat. No.: V651929 Formule: C18H25F3N4O3 Poids moléculaire: 402.41
DISPONIBLE À COMMANDE
QUALITÉ & PURETÉ ≥99%
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Taille
Allemagne (EU)
USA*
Prix
Qté
1mg
V651929-1mg
Sur commande · 8–12 semaines
330,52€
5mg
V651929-5mg
Sur commande · 8–12 semaines
1 024,71€
10mg
V651929-10mg
Sur commande · 8–12 semaines
1 545,36€
Enter a quantity for the sizes you want to add.

Vue d’ensemble

Vps34-IN-2 is a novel, potent and selective inhibitor of Vps34 with IC 50 s of 2 and 82 nM on the Vps34 enzymatic assay and the GFP-FYVE cellular assay, respectively Vps34-IN-2 shows antiviral activity against SARS-CoV-2 ( IC 50 of 3.1 μM), HCoV-229E ( IC 50 of 0.7 μM) and HCoV-OC43 .

In Vitro

Vps34-IN-2 (Compound 31) displays IC 50 s of 2 and 82 nM on the Vps34 enzymatic assay and the GFP-FYVE cellular assay, respectively. Vps34-IN-2 exhibits selectivity against mTOR (IC 50 >10 μM) and class I PI3Ks (IC 50 values of 2.7, 4.5, 2.5, and >10 μM on PI3K α, β, δ, γ isoforms, respectively). MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

After administration by the intravenous (iv) route, Vps34-IN-2 (Compound 31) concentrations are quantifiable up to 6, 8, and 24 h (last sampling time) depending on animals. After oral administration (po), Vps34-IN-2 is rapidly absorbed with maximal plasma concentrations observed at 0.5 h and a bioavailability of 85%. Slight rebounds of concentrations are observed at 4 and 8 h after oral dosing with no obvious explanation. After iv injection of Vps34-IN-2 at 3 mg/kg, plasma clearance is found moderate (i.e., 2.3 L/h/kg), corresponding to 44% of hepatic blood flow in this species, volume of distribution at steady state is moderate, and terminal elimination half-life is short . MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Form:Solid

IC50& Target:Vps34|2 nM (IC|50|)|SARS-CoV-2|3.1 μM (IC|50|)|HCoV-229E|0.7 μM (IC|50|)

Spécifications

Spécifications et pureté
≥99%
Mécanismes biochimiques et physiologiques
Vps34-IN-2 is a novel, potent and selective inhibitor of Vps34 with IC 50 s of 2 and 82 nM on the Vps34 enzymatic assay and the GFP-FYVE cellular assay, respectively. Vps34-IN-2 shows antiviral activity against SARS-CoV-2 ( IC 50 of 3.1 μM), HCoV-229
Conditions de stockage de stockage
Store at -20°C
Expédié en
Ice chest + Ice pads
Ce produit nécessite l'expédition en chaîne froide. Les services terrestres et autres services économiques ne sont pas disponibles.
Pureté
≥99%
Noms et identifiants
Poids moléculaire
402.41

Données avancées

Certificats (CoA, COO, BSE/TSE et tableau d'analyse)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Propriétés chimiques et physiques
SolubilitéEthanol : 50 mg/mL (124.25 mM; Need ultrasonic)
Calculateurs de solution
Avis

Avis des clients

Foire aux questions

What is the purity of this product?
This product is supplied at ≥99% purity (chemical assay). Lot-specific values are stated on the Certificate of Analysis.
How should this product be stored?
Store at ?20 °C. Freezer storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 1523404-29-6, the molecular formula is C18H25F3N4O3, and the molecular weight is 402.41 g/mol.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Souhaitez-vous que nous vous envoyions un message lorsque des réductions seront disponibles?

Me rappeler plus tard

Merci ! Veuillez vérifier votre boîte de réception e-mail pour confirmer.

Oups ! Les notifications sont désactivées.